Melanoma, a malignant tumor arising from melanocytes, remains a leading cause of skin cancer-related deaths. Despite advancements in treatment, its prognosis is often poor in advanced stages. Emerging research suggests that the microbiome the collection of microorganisms living in and on the human body may influence melanoma development and progression. This article explores the connection between melanoma and the microbiome, detailing how microbial communities could affect disease outcomes and potentially guide novel therapeutic approaches.
HTML PDFShare this article
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report
